Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Undiagnosed Diseases Network, |
RCV000791266 | SCV000930550 | uncertain significance | TONSL-related disorder | 2016-11-01 | criteria provided, single submitter | clinical testing | This individual has been reported in PMID: 30773277 (family 7). |
Labcorp Genetics |
RCV001869238 | SCV002226112 | uncertain significance | not provided | 2022-08-19 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 199 of the TONSL protein (p.Glu199Lys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of sponastrime dysplasia (PMID: 30773277). ClinVar contains an entry for this variant (Variation ID: 638067). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
OMIM | RCV000790533 | SCV000929865 | pathogenic | Sponastrime dysplasia | 2019-07-24 | no assertion criteria provided | literature only | |
University of Washington Center for Mendelian Genomics, |
RCV001261770 | SCV001439086 | likely pathogenic | Skeletal dysplaisia with extra-skeletal manifestations | no assertion criteria provided | research |